Singapore, 13 July 2023 – EVYD Technology and the Agency for Science, Technology and Research (A*STAR) have established a joint lab to advance AI research for population health
Dr. Mei Yang is a seasoned healthcare executive with over 15 years of experience in RWE, AI, and healthcare analytics. As CEO of EVYD Technology US, she leads the company’s mission to transform healthcare through AI-powered solutions. Prior to EVYD, Dr. Yang held leadership roles at Merck, Daiichi Sankyo, AbbVie, and Yidu Tech Life Science, where she spearheaded AI-driven RWE strategies, predictive analytics, and data-driven market access solutions. Her expertise in biostatistics, epidemiology, and AI has led to significant advancements in clinical development, regulatory submissions, and payer decision-making. Dr. Yang is a recognized thought leader with over 40 peer-reviewed publications in top-tier medical and economic journals. She holds a Ph.D. in Biostatistics from Boston University’s School of Public Health.
Jiming serves as the Chief Executive Officer and Chief Technology Officer of EVYD Technology, bringing over a decade of experience in big data, healthcare and artificial intelligence. He is also the Co-founder and CEO of Yidu Tech Inc., a leading AI-driven healthcare solutions provider founded in 2014, focused on advancing precision medicine through data intelligence and innovation. Prior to his roles at EVYD Technology and Yidu Tech, Jiming held senior positions in technology and innovation, including roles at Baidu and Alibaba’s mobile business division, where he focused on advancing search engine technology and big data applications. Jiming holds a bachelor’s degree in Automation from Tsinghua University and a master’s degree in Computer Application Technology from the Graduate School of the Chinese Academy of Sciences. He co-authored the paper “Application of AI Technology in Drug Development,” published in Nature Medicine in 2019.
Ms. Feng Xiaoying serves as an executive director and the CFO of Yidu Tech Inc. She obtained her Bachelor’s degree in Management from the School of Economics and Management at Tsinghua University in 2001 and holds certifications as a Chartered Professional Accountant in Canada and a Certified Public Accountant in China. Prior to joining Yidu Tech, Ms. Feng held positions at PricewaterhouseCoopers, Deloitte, China Minsheng Investment Group, and other institutions. She served as the executive director and deputy chief executive officer of China Minsheng Financial Holdings Corporation Limited from December 2015 to February 2018, and as the executive vice president and chief financial officer of OFO (HK) Limited from February 2018 to May 2019. Under her leadership, her team has received several prestigious awards, including the 6th NewFortune Best Investor Relations Team Award (Hong Kong listed company), the 2022 Capital Market “Golden Sail” Excellent Technology Value Listed Company Award by 21st Century Business Herald, the Best IR Team Award at the 7th Zhitong Caijing Capital Market Annual Meeting, and the IRSC 2022–2023 Best Shareholder Relations Award.
Kangning Cai serves as the Head of Product Management at Evyd, where he leads the Product Architecture and Development team. In this capacity, he is responsible for overseeing the company’s product portfolio management and application architecture, while directing his team in delivering innovative product development outcomes. He specializes in pioneering big data and AI solutions in healthcare, driving technological innovations that advance Evyd’s position in the industry. With over 5 years of experience in healthcare AI and big data analytics, Kangning Cai has spearheaded key initiatives addressing fundamental challenges in healthcare data integration, quality improvement, and analysis. He has led the development of medical data platforms and pioneered predictive models for multiple diseases, delivering data-driven solutions that enable medical research discoveries and epidemiological risk analysis for government agencies and healthcare institutions. His expertise lies in identifying practical healthcare challenges and architecting tailored digital solutions that enhance operational efficiency, service quality, and economic outcomes for healthcare stakeholders. He is known for his expertise in transforming complex healthcare data challenges into actionable insights and his commitment to driving healthcare innovation through technology-enabled solutions. Kangning is a Ph.D. candidate in Public Health at Tsinghua University, with a Master’s degree in Information Systems and Data Science from Johns Hopkins University. He is dedicated to bringing together expertise in data analytics and public health research.
Tang Yu serves as the Head of Security at EVYD Technology, where he leads the company’s cybersecurity strategy, ensuring the protection and privacy of healthcare data. He drives compliance with international standards such as ISO 27001 and HIPAA, oversees the SOC 2 Type 2 certification process, and implements innovative security solutions for EVYD’s big data platforms. His work supports the company’s mission to transform healthcare through secure and scalable technology. Tang Yu brings extensive leadership experience from previous roles, including AVP at DBS Bank, where he developed enterprise-wide security strategies for financial systems; Senior Enterprise Security Architect at JD.com, where he designed secure architectures for one of the largest e-commerce platforms; and Chief Information Security Officer at Haier Cosmoplat, where he led the digital transformation of a global industrial IoT platform with robust data security measures. Tang Yu holds a Master’s degree in Software Engineering from Blekinge Institute of Technology (BTH) in Sweden. A certified CISSP and AWS Security Specialist, he is recognized for his expertise in building resilient and innovative digital ecosystems. Tang Yu’s career reflects his dedication to advancing technology with a focus on security, trust, and compliance, ensuring robust solutions for a dynamic digital landscape.
Kelvin Ho, Senior Commercial Director, EVYD Technology. Kelvin Ho is a seasoned executive with over 17 years’ experience driving commercial growth and innovation, particularly in healthcare. Currently, he serves as Senior Director, Commercial at EVYD Technology. Over his career, Kelvin has held various leadership roles in government, corporations and startups. Notably, he led industry growth and transformation efforts as Head, Biomedical Sciences at the Singapore Economic Development Board. He later joined global reinsurer Swiss Re to bring life and health reinsurance solutions to the APAC market. Most recently he served as VP of Commercial Development at cancer biotech Mirxes, leading the commercial team and establishing key local partnerships. On the side, Kelvin is also a founding leader of the Digital Health Society of SEA. Kelvin holds an MBA from UCLA Anderson School of Management and a Bachelor of Science in Biomedical Engineering from Duke University.
Peiyan(Perry) Ning, Head of Technology at EVYD Technology, leverages over 15 years in big data and AI architecture to lead software engineering, data engineering, and infrastructure teams. In past 3 years, he led the design of a large-scale secure hybrid cloud infrastructure for a vast network of healthcare and government clients, developed a platform for medical big data processing and analysis, and implemented AI-based healthcare applications.
Prior to this, he worked at China’s largest e-commerce company, where he contributed to a comprehensive upgrade and transformation of the platform’s technical architecture, laying a solid foundation for its future development.
William Lai, Director of Project Management and Customer Success, EVYD Technology. William Lai leads project management and customer success at EVYD Technology, leveraging over 16 years of experience to lead EVYD’s operational transformation. He optimizes processes and foster high-performing teams, driving efficiency and exceptional customer experiences. Previously, William progressed through various roles from Analyst to Head of Operations at Dynamik Technologies (formerly BAG Networks), implementing improvements across IT, finance, health and more. William holds a BSc in Mathematics from Universiti Brunei Darussalam (UBD).
Abby Tan, General Manager, EVYD Technology. Abby Tan blends academic achievement, research expertise, and industry experi-ence to his role as General Manager at EVYD Technology. A recognized leader in mathematics and technology, he drove innovation at universities and private sectors. Previously at Universiti Brunei Darussalam (UBD), he rose from lecturer to Vice President, spearheading research that propelled UBD to publication highs. Currently at EVYD, Abby leverages his expertise to guide healthcare technology de-velopment while continuing his research evident in his publications in top journals. Abby holds a PhD in Mathematics from Manchester University, following his First-Class Honors Bachelor’s degree in the same field from University of Manchester In-stitute of Science and Technology (UMIST).
As Head of Medical and Data Science, EVYD Technology, Dr Joshua Lam leads the Medical and Data Science team, leveraging his background in informatics and data science. Previously, as Data Architect at Singapore Health Promotion Board, he designed standardized person-centric data models for healthcare programs and citizen wellness initiatives. Earlier, as Lead Informatics Specialist at IHiS, he streamlined clinical data for the National Electronic Health Record. Dr Joshua brings valuable real-world experience as a practicing medical doctor across various specialties and care settings. This dual expertise positions him perfectly to bridge the gap between clinical practice and data-driven healthcare advancements at EVYD. Joshua holds a Bachelor of Medicine and Bachelor of Surgery and Postgraduate Diploma in Family Medicine from the National University of Singapore and made Dean’s List during his Master of IT in Business (Specialization in Data Analytics) at Singapore Management University.
Associate Professor Jeremy Lim is the Director of the Leadership Institute for Global Health Transformation at Saw Swee Hock School of Public Health, National University of Singapore, where he leads the initiatives in health systems strengthening and universal health coverage. He brings diverse and unique perspectives having spent substantial time in public and private healthcare across Asia as well as in policy advisory with Singapore’s Ministry of Health, the World Bank and the World Health Organization. Outside academia, Jeremy serves on the boards of various for-profit and not-for-profit organizations in different aspects of healthcare including migrant worker health, end of life care and digital health interventions. He trained in surgery and public health, attaining post-graduate qualifications in both from the UK and US.
Jennifer serves in Temasek Foundation’s leadership team and heads the Philanthropy Advocates Practice. She is responsible for the strategic management of the Foundation’s internal and external communication and engagement activities. Prior to this, she had been with GIC Private Limited for 12 years where she was also managing strategic communications for the sovereign wealth fund. She began her corporate communications journey after more than twenty years as a journalist with television, print and online experience. She also advises several AI and digital asset start-ups.
Su has over 15 years of experience at the Brunei Investment Agency, where she currently serves as the Head of Alternative Assets. She is responsible for overseeing the strategy and execution of all private equity deals, as well as the absolute return and commodity-related investments. Su serves on the board of Boqii Holdings and was involved in its recent IPO on the New York Stock Exchange. She also sits on the board of several companies across varying sectors, such as the tourism, financial and agri-tech industries. Su holds a bachelor of science degree in Economics from the International Islamic University in Malaysia, and a master of science in Finance and Economics from the Manchester Business School. She is a CFA Charter holder and holds the Chartered Alternative Investment Analyst designation from the CAIA Association. In 2018, she completed the Program for Leadership Development at the Harvard Business School.
Rujing is the Executive Director, Chief Executive Officer, Chairwoman and Founder of Yidu Tech, a leading medical Big Data and Artificial Intelligence (AI) company based in China. Rujing has extensive investment and industry experience. She established the Beijing Huixu Jintong Investment Center, a private equity fund focused on investments in healthcare and technology, as well as the Guizhou Province Xiao Yingying Charity Foundation that supports children with rare and major illnesses. Before starting Yidu Tech, Rujing co-founded HKtrust Capital, a healthcare-focused investment fund, after working at Deutsche Bank and Global Infrastructure Partners during the early years of her career. Rujing holds a bachelor’s degree in Economics from the London School of Economics and received an Executive MBA from the Cheung Kong Graduate School of Business.
Dr. Amin Liew currently serves as the Minister at The Prime Minister’s Office and Minister of Finance and Economy II. He also sits on the board of a number of government-linked companies across a range of industries, including telecommunications, medical services, hospitality, aviation, oil and gas, IT and education. Dr. Amin Liew previously served as the Minister of Finance II, the Deputy Minister of Finance (Investment), and the Chief Executive Officer of Darussalam Assets Sdn Bhd. He has held several key positions with the Brunei Government, including as the Permanent Secretary of the Ministry of Finance, the Permanent Secretary of the Ministry of Industry and Primary Resources and the Managing Director of the Brunei Investment Agency. Dr. Amin Liew received his master’s degree in Management and a PhD in Corporate Finance from Imperial College London. Dr. Amin Liew also holds a professional qualification as a Chartered Financial Analyst (CFA) and is an active member of the CFA Institute in Singapore.
Mao Xufeng,
Yi Li,
Dr. Pijika Watcharapichat, MD, PhD Medical Director, EVYD Technology. Dr Pijika Watcharapichat, EVYD Technology’s Medical Director, bridges medicine and technology. Combining her MD with honors (Chulalongkorn University) and PhD in Computer Science specializing in large-scale machine learning (Imperial College London), she tackles healthcare challenges. Expertise in nutrition science (Stanford University) and lifestyle medicine empowers her to tackle chronic diseases. With over 15 years of experience, AI research, and clinical trials at GSK and Microsoft, Dr Pijika leads research on Thai dietary patterns to combat chronic diseases. A champion for lifestyle medicine, Dr Pijika co-authored a well-received guidebook simplifying health science and empowering individuals to manage their health through lifestyle changes.
Zhao Li, Director of Product, EVYD Technology. Zhao Li leverages his expertise to design and build healthcare solutions across Asia and the US. Throughout his career, he has championed user-centricity, driving product development that empowers users and improves health outcomes. Prior to EVYD, Zhao Li led product teams at iHospital (AstraZeneca), expanding the online sales channels for core pharmaceutical products and enhancing patient-hospital connections. At Ping An Health, he led user growth initiatives and explored data-driven commercialization of health management services. Zhao Li holds a Master’s in Information System Engineering from the University of Manchester and a dual Bachelor’s degree in Information System and Management, and Business from Shanghai University.
